Forbes cites CB Insights’ recent report on the state of venture capital in digital health for the third quarter of 2022. Investing in startups has decreased, according to its main conclusion.
There was a 31% decline in digital healthcare startups, which saw $5 billion invested, a number that hasn’t been that low since the third quarter of 2019. A total of $2.9 billion was invested across 231 deals in the U.S., while $1.3 billion was invested across 94 deals in Asia.
For 2022, the average deal size has declined to $16 million, down from $25 million in 2021. Compared to the second quarter, only three startups became unicorns with valuations over $1 billion in the third quarter.